ID LHPP_HUMAN Reviewed; 270 AA. AC Q9H008; B3KP20; Q2TBE9; Q5VUV9; Q5VUW0; DT 02-OCT-2007, integrated into UniProtKB/Swiss-Prot. DT 02-OCT-2007, sequence version 2. DT 24-JAN-2024, entry version 157. DE RecName: Full=Phospholysine phosphohistidine inorganic pyrophosphate phosphatase; DE Short=hLHPP; DE EC=3.1.3.-; DE EC=3.6.1.1; GN Name=LHPP; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBUNIT, CATALYTIC ACTIVITY, RP COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY, AND VARIANT RP ARG-94. RC TISSUE=Cervix carcinoma; RX PubMed=12801912; DOI=10.1093/jb/mvg078; RA Yokoi F., Hiraishi H., Izuhara K.; RT "Molecular cloning of a cDNA for the human phospholysine phosphohistidine RT inorganic pyrophosphate phosphatase."; RL J. Biochem. 133:607-614(2003). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ARG-94. RC TISSUE=Heart; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164054; DOI=10.1038/nature02462; RA Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., RA Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., RA Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., RA Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P., RA Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J., RA Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y., RA Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P., RA Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N., RA Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A., RA Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C., RA Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D., RA Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C., RA Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K., RA Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A., RA Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S., RA McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S., RA Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., RA Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., RA Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., RA Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A., RA Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P., RA Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y., RA Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D., RA Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.; RT "The DNA sequence and comparative analysis of human chromosome 10."; RL Nature 429:375-381(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT RP ARG-94. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RX PubMed=16430861; DOI=10.1016/j.bbrc.2006.01.016; RA Koike E., Toda S., Yokoi F., Izuhara K., Koike N., Itoh K., Miyazaki K., RA Sugihara H.; RT "Expression of new human inorganic pyrophosphatase in thyroid diseases: its RT intimate association with hyperthyroidism."; RL Biochem. Biophys. Res. Commun. 341:691-696(2006). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [7] RP X-RAY CRYSTALLOGRAPHY (1.92 ANGSTROMS) IN COMPLEX WITH SUBSTRATE ANALOG AND RP MAGNESIUM IONS, AND COFACTOR. RG Structural genomics consortium (SGC); RT "Crystal structure of human phospholysine phosphohistidine inorganic RT pyrophosphate phosphatase LHPP."; RL Submitted (MAR-2010) to the PDB data bank. CC -!- FUNCTION: Phosphatase that hydrolyzes imidodiphosphate, 3- CC phosphohistidine and 6-phospholysine. Has broad substrate specificity CC and can also hydrolyze inorganic diphosphate, but with lower efficiency CC (By similarity). {ECO:0000250}. CC -!- CATALYTIC ACTIVITY: CC Reaction=diphosphate + H2O = H(+) + 2 phosphate; Xref=Rhea:RHEA:24576, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:43474; EC=3.6.1.1; CC Evidence={ECO:0000269|PubMed:12801912}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000269|PubMed:12801912, ECO:0000269|Ref.7}; CC Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000269|PubMed:12801912, CC ECO:0000269|Ref.7}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC pH dependence: CC Optimum pH is 7.0 for PNP, and 5.5 for PPi. CC {ECO:0000269|PubMed:12801912}; CC -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:12801912, ECO:0000269|Ref.7}. CC -!- INTERACTION: CC Q9H008; Q3MJ62: ZSCAN23; NbExp=3; IntAct=EBI-1059330, EBI-5667532; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16430861}. Nucleus CC {ECO:0000269|PubMed:16430861}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9H008-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9H008-2; Sequence=VSP_041685, VSP_041686; CC -!- TISSUE SPECIFICITY: Expressed in brain, and at lower levels in liver CC and kidney. Detected in thyroid (at protein level). Expressed in liver, CC kidney and moderately in brain. {ECO:0000269|PubMed:12801912, CC ECO:0000269|PubMed:16430861}. CC -!- SIMILARITY: Belongs to the HAD-like hydrolase superfamily. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB049629; BAB16411.1; -; mRNA. DR EMBL; AK055532; BAG51532.1; -; mRNA. DR EMBL; AL513190; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL391708; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL445237; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC110344; AAI10345.1; -; mRNA. DR EMBL; BC113629; AAI13630.1; -; mRNA. DR EMBL; BC113631; AAI13632.1; -; mRNA. DR CCDS; CCDS53587.1; -. [Q9H008-2] DR CCDS; CCDS7640.1; -. [Q9H008-1] DR RefSeq; NP_001161352.1; NM_001167880.1. [Q9H008-2] DR RefSeq; NP_001305260.1; NM_001318331.1. DR RefSeq; NP_001305261.1; NM_001318332.1. DR RefSeq; NP_071409.3; NM_022126.3. [Q9H008-1] DR PDB; 2X4D; X-ray; 1.92 A; A/B=1-270. DR PDBsum; 2X4D; -. DR AlphaFoldDB; Q9H008; -. DR SMR; Q9H008; -. DR BioGRID; 122044; 37. DR IntAct; Q9H008; 1. DR STRING; 9606.ENSP00000357835; -. DR ChEMBL; CHEMBL5169196; -. DR DEPOD; LHPP; -. DR iPTMnet; Q9H008; -. DR PhosphoSitePlus; Q9H008; -. DR BioMuta; LHPP; -. DR DMDM; 158705883; -. DR EPD; Q9H008; -. DR jPOST; Q9H008; -. DR MassIVE; Q9H008; -. DR MaxQB; Q9H008; -. DR PaxDb; 9606-ENSP00000357835; -. DR PeptideAtlas; Q9H008; -. DR ProteomicsDB; 80192; -. [Q9H008-1] DR ProteomicsDB; 80193; -. [Q9H008-2] DR Pumba; Q9H008; -. DR Antibodypedia; 1952; 149 antibodies from 23 providers. DR DNASU; 64077; -. DR Ensembl; ENST00000368839.1; ENSP00000357832.1; ENSG00000107902.14. [Q9H008-2] DR Ensembl; ENST00000368842.10; ENSP00000357835.5; ENSG00000107902.14. [Q9H008-1] DR GeneID; 64077; -. DR KEGG; hsa:64077; -. DR MANE-Select; ENST00000368842.10; ENSP00000357835.5; NM_022126.4; NP_071409.3. DR UCSC; uc001lhs.3; human. [Q9H008-1] DR AGR; HGNC:30042; -. DR CTD; 64077; -. DR DisGeNET; 64077; -. DR GeneCards; LHPP; -. DR HGNC; HGNC:30042; LHPP. DR HPA; ENSG00000107902; Tissue enriched (brain). DR MIM; 617231; gene. DR neXtProt; NX_Q9H008; -. DR OpenTargets; ENSG00000107902; -. DR PharmGKB; PA165548763; -. DR VEuPathDB; HostDB:ENSG00000107902; -. DR eggNOG; KOG3040; Eukaryota. DR GeneTree; ENSGT00940000159002; -. DR HOGENOM; CLU_043473_4_1_1; -. DR InParanoid; Q9H008; -. DR OMA; GPCIDVG; -. DR OrthoDB; 2876640at2759; -. DR PhylomeDB; Q9H008; -. DR TreeFam; TF314344; -. DR BRENDA; 3.9.1.3; 2681. DR PathwayCommons; Q9H008; -. DR Reactome; R-HSA-71737; Pyrophosphate hydrolysis. DR SignaLink; Q9H008; -. DR BioGRID-ORCS; 64077; 5 hits in 1174 CRISPR screens. DR ChiTaRS; LHPP; human. DR GenomeRNAi; 64077; -. DR Pharos; Q9H008; Tbio. DR PRO; PR:Q9H008; -. DR Proteomes; UP000005640; Chromosome 10. DR RNAct; Q9H008; Protein. DR Bgee; ENSG00000107902; Expressed in C1 segment of cervical spinal cord and 138 other cell types or tissues. DR ExpressionAtlas; Q9H008; baseline and differential. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0016607; C:nuclear speck; IDA:HPA. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0004427; F:inorganic diphosphate phosphatase activity; IDA:UniProtKB. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0016791; F:phosphatase activity; IBA:GO_Central. DR GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB. DR GO; GO:0016311; P:dephosphorylation; IEA:InterPro. DR GO; GO:0006796; P:phosphate-containing compound metabolic process; IDA:UniProtKB. DR CDD; cd07509; HAD_PPase; 1. DR Gene3D; 3.40.50.1000; HAD superfamily/HAD-like; 2. DR InterPro; IPR036412; HAD-like_sf. DR InterPro; IPR006357; HAD-SF_hydro_IIA. DR InterPro; IPR023214; HAD_sf. DR InterPro; IPR006355; LHPP/HDHD2. DR NCBIfam; TIGR01460; HAD-SF-IIA; 1. DR NCBIfam; TIGR01458; HAD-SF-IIA-hyp3; 1. DR PANTHER; PTHR19288; 4-NITROPHENYLPHOSPHATASE-RELATED; 1. DR PANTHER; PTHR19288:SF44; PHOSPHOLYSINE PHOSPHOHISTIDINE INORGANIC PYROPHOSPHATE PHOSPHATASE; 1. DR Pfam; PF13344; Hydrolase_6; 1. DR Pfam; PF13242; Hydrolase_like; 1. DR SFLD; SFLDG01129; C1.5:_HAD__Beta-PGM__Phosphata; 1. DR SFLD; SFLDG01139; C2.A:_Pyridoxal_Phosphate_Phos; 1. DR SFLD; SFLDS00003; Haloacid_Dehalogenase; 2. DR SUPFAM; SSF56784; HAD-like; 1. DR Genevisible; Q9H008; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Cytoplasm; Hydrolase; Magnesium; KW Metal-binding; Nucleus; Reference proteome. FT CHAIN 1..270 FT /note="Phospholysine phosphohistidine inorganic FT pyrophosphate phosphatase" FT /id="PRO_0000305074" FT BINDING 17..19 FT /ligand="substrate" FT BINDING 17 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT BINDING 19 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT BINDING 54..55 FT /ligand="substrate" FT BINDING 189 FT /ligand="substrate" FT BINDING 214 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT VAR_SEQ 210 FT /note="V -> Q (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_041685" FT VAR_SEQ 211..270 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_041686" FT VARIANT 94 FT /note="Q -> R (in dbSNP:rs6597801)" FT /evidence="ECO:0000269|PubMed:12801912, FT ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334" FT /id="VAR_035163" FT CONFLICT 155 FT /note="K -> R (in Ref. 2; BAG51532)" FT /evidence="ECO:0000305" FT CONFLICT 170 FT /note="G -> C (in Ref. 4; AAI10345)" FT /evidence="ECO:0000305" FT HELIX 4..7 FT /evidence="ECO:0007829|PDB:2X4D" FT TURN 8..10 FT /evidence="ECO:0007829|PDB:2X4D" FT STRAND 13..16 FT /evidence="ECO:0007829|PDB:2X4D" FT TURN 19..21 FT /evidence="ECO:0007829|PDB:2X4D" FT STRAND 22..24 FT /evidence="ECO:0007829|PDB:2X4D" FT TURN 27..29 FT /evidence="ECO:0007829|PDB:2X4D" FT HELIX 36..45 FT /evidence="ECO:0007829|PDB:2X4D" FT STRAND 46..53 FT /evidence="ECO:0007829|PDB:2X4D" FT HELIX 61..70 FT /evidence="ECO:0007829|PDB:2X4D" FT HELIX 77..79 FT /evidence="ECO:0007829|PDB:2X4D" FT HELIX 83..94 FT /evidence="ECO:0007829|PDB:2X4D" FT STRAND 98..101 FT /evidence="ECO:0007829|PDB:2X4D" FT HELIX 104..110 FT /evidence="ECO:0007829|PDB:2X4D" FT STRAND 119..123 FT /evidence="ECO:0007829|PDB:2X4D" FT HELIX 127..129 FT /evidence="ECO:0007829|PDB:2X4D" FT HELIX 132..144 FT /evidence="ECO:0007829|PDB:2X4D" FT STRAND 150..153 FT /evidence="ECO:0007829|PDB:2X4D" FT STRAND 157..161 FT /evidence="ECO:0007829|PDB:2X4D" FT STRAND 164..167 FT /evidence="ECO:0007829|PDB:2X4D" FT HELIX 169..180 FT /evidence="ECO:0007829|PDB:2X4D" FT STRAND 185..188 FT /evidence="ECO:0007829|PDB:2X4D" FT HELIX 192..202 FT /evidence="ECO:0007829|PDB:2X4D" FT HELIX 206..208 FT /evidence="ECO:0007829|PDB:2X4D" FT STRAND 209..214 FT /evidence="ECO:0007829|PDB:2X4D" FT TURN 216..219 FT /evidence="ECO:0007829|PDB:2X4D" FT HELIX 220..225 FT /evidence="ECO:0007829|PDB:2X4D" FT STRAND 229..235 FT /evidence="ECO:0007829|PDB:2X4D" FT HELIX 240..244 FT /evidence="ECO:0007829|PDB:2X4D" FT STRAND 251..256 FT /evidence="ECO:0007829|PDB:2X4D" FT HELIX 257..267 FT /evidence="ECO:0007829|PDB:2X4D" SQ SEQUENCE 270 AA; 29165 MW; 09C301584453E79D CRC64; MAPWGKRLAG VRGVLLDISG VLYDSGAGGG TAIAGSVEAV ARLKRSRLKV RFCTNESQKS RAELVGQLQR LGFDISEQEV TAPAPAACQI LKEQGLRPYL LIHDGVRSEF DQIDTSNPNC VVIADAGESF SYQNMNNAFQ VLMELEKPVL ISLGKGRYYK ETSGLMLDVG PYMKALEYAC GIKAEVVGKP SPEFFKSALQ AIGVEAHQAV MIGDDIVGDV GGAQRCGMRA LQVRTGKFRP SDEHHPEVKA DGYVDNLAEA VDLLLQHADK //